Jun 21 |
Should You Sell Your Stake in RAPT Therapeutics (RAPT)?
|
Jun 14 |
Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
|
May 29 |
Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
May 20 |
RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
|
May 14 |
Wolfe downgrades RAPT, but still sees "immense" upside potential
|
May 13 |
Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
|
May 12 |
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
|
May 10 |
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
|
May 10 |
RAPT falls for second day as Guggenheim, Barclays downgrade stock
|
May 9 |
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
|